Impact BioMedical
Share
Improving health outcomes in innovative ways based on nature's wisdom.
02/06/2025
Impact BioMedical's COO, Mark Suseck, will be attending BIO CEO next week in NYC! If you'll be in town, let’s connect—reach out to schedule a meeting and we look forward to great conversations! 💬🔬
✨ ICYMI: Catch the Impact BioMedical (NYSE American: IBO) management team as they delve into their four core platform technologies and explain how these align with the company’s unique business model! ✨
03/25/2024
Impact Biomedical is dedicated to leveraging the latest advancements in technology for critical research towards creating a healthier world.
Our continuous commitment to staying at the forefront of tech trends allows us to make significant strides in our mission.
Learn more at impactbiomedinc.com
11/09/2023
Impact Biomedical, a human healthcare and wellness company and subsidiary of DSS, Inc. (NYSE American: DSS), has filed a Current Report on Form 8K on November 6, 2023, disclosing that Impact effected a reverse stock split of its issued and outstanding common stock by a ratio of 1 for 55.
“Existing Impact common stockholders, who previously held approximately 12% of the outstanding common stock of Impact, will now hold approximately 88% of the company’s common stock shares.”
-Frank Heuszel, CEO of DSS, Inc.
Learn more → https://finance.yahoo.com/news/dss-inc-subsidiary-files-current-133100219.html
Click here to claim your Sponsored Listing.
Category
Website
Address
1400 Broadfield Boulevard , Suite 130
Houston, TX
77084
